Sandoz Talks US Biosimilars And Misinformation

Q&A With Hillel Cohen, Sandoz' Executive Director, Scientific Affairs

 
• By Dean Rudge
  
Generate a summary of this article
Listen to this article
Beta

Increasing access and use of lower cost biosimilars by combatting disparagement and misinformation is more important now than ever, as the COVID-19 pandemic cripples economies across the globe, argues Sandoz’ executive director for scientific affairs, Hillel Cohen.

Interview_2020_2
• Source: Informa

Last month, in an opinion piece for the biologic therapies journal BioDrugs, Sandoz’ executive director for scientific affairs, Hillel Cohen, argued that the slow uptake of biosimilars in some markets may stem in part from patients and healthcare providers being subjected at times to “misleading, incomplete, out-of-context, and at times incorrect information about biosimilars.” (Also see "Misinformation Contributing To Slower Biosimilar Uptake, Execs Claim" - Generics Bulletin, 23 July, 2020.)

Sandoz has been among the leaders of efforts to dispel myths around biosimilars and drive education, recently launching in Canada...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.